RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R10882 | Sunitinib (Synonyms: SU 11248) | Sunitinib Malate is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and |
| R10859 | Tacrolimus; FK506 | Tacrolimus (FK506) is a 23-membered macrolide lactone, it reduces peptidyl-proly |
| R10891 | Vatalanib | Vatalanib (PTK787) 2HCl is an inhibitor of VEGFR2/KDR with IC50 of 37 nM in a ce |
| R10845 | Veliparib;ABT-888 | Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM a |
| R10892 | VX-222; VCH-222; Lomibuvir | VX-222 (VCH-222) is a novel, potent and selective inhibitor of HCV polymerase wi |
| R10893 | JNJ38431055; APD-597 | APD597 is a GPR119 agonist intended for the treatment of type 2 diabetes, with E |
| R10895 | Tasimelteon | N/A |
| R10896 | Helioxanthin; ACH126447 | Helioxanthin(ACH126447) and its analogues exhibit significant in vitro antiviral |
| R10897 | SYM2206 | SYM 2206 is a novel, potent, non-competitive AMPA receptor antagonist (IC50= 2.8 |
| R10898 | Lorlatinib (Synonyms: PF-06463922) | PF-06463922 is a potent, dual ALK/ROS1 inhibitor with Ki of <0.02 nM, <0.0 |
| R10899 | GSK269962A (Synonyms: GSK 269962) | GSK269962A(GSK269962) is a potent ROCK inhibitor (IC50 values are 1.6 and 4 nM f |
| R10900 | CL-387785 ; EKI-785 | CL-387785(EKI785; WAY-EKI 785) is an irreversible inhibitor of EGFR with IC50 of |
| R10901 | MCC950 sodium (Synonyms: CP-456773 sodium; CRID3 sodium salt) | MCC950 (CP-456773) sodium is a potent, selective, small-molecule inhibitor of NL |
| R10902 | MCC950;CP-456773;CRID3 | MCC950 (CP-456773) sodium is a potent, selective, small-molecule inhibitor of NL |
| R10903 | CEP-33779 | CEP33779 is a selective JAK2 inhibitor with IC50 of 1.8 nM, >40- and >800- |
| R10904 | Irbinitinib; ARRY-380; ONT-380 | Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor with IC5 |
| R10905 | XL147; SAR245408 | XL147 analogue is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/ |
| R10906 | GSK163090 | GSK163090 is a potent, selective, and orally active 5-HT1A/B/D receptor antagoni |
| R10907 | AMG319 | AMG319 is a potent and selective PI3Kδ inhibitor with IC50 of 18 nM, >47-fold |
| R10908 | UNC-2025; UNC2025 | UNC2025 is a potent and orally bioavailable Mer/Flt3 dual inhibitor with IC50 of |
| R10910 | MK-8776 | MK-8776 (SCH 900776) is a selective Chk1 inhibitor with IC50 of 3 nM in a cell-f |
| R10911 | Motolimod;VTX-2337; VTX-378 | Motolimod (VTX-2337) is a selective and potent Toll-like receptor (TLR) 8 agonis |
| R10912 | Darolutamide; ODM-201; BAY-1841788 | ODM-201 is a novel androgen receptor (AR) antagonist that blocks AR nuclear tran |
| R10913 | Vipadenant; BIIB014 | Vipadenant(BIIB-014) is an adenosine A2a antagonist with Ki of 1.3 nM; less pote |
| R10914 | RGB-286638 | RGB-286638 free base is a novel CDK inhibitor with IC50s of 1 nM/2 nM/3 nM/4 nM/ |
